Business
‘Robust immune responses’: Oxford virus trial offers hope for elderly – The New Daily
Oxford University-AstraZeneca’s coronavirus vaccine has produced a robust immune response in elderly people, according to early test results.
The COVID-19 vaccine being developed by the University of Oxford produces an immune response in both elderly and young people and adverse reactions were lower among the elderly, British drug maker AstraZeneca says.
A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, hammered the global economy and shuttered normal life across the world.
The Financial Times reported the vaccine, being developed by Oxford and AstraZeneca,…
-
General22 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
Noosa News21 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General13 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat
-
Noosa News22 hours agoThe Best Things to Do in Brisbane This New Year’s Eve